Advertisement

Topics

Recro Pharma’s Shares Plunges Following FDA Letter

18:55 EDT 24 May 2018 | Investing News Network

Following the announcement on Thursday, shares of Recro Pharma dropped in dramatic fashion by nearly 55 percent to close the trading day at $5.63.

The post Recro Pharma’s Shares Plunges Following FDA Letter appeared first on Investing News Network.

Original Article: Recro Pharma’s Shares Plunges Following FDA Letter

NEXT ARTICLE

More From BioPortfolio on "Recro Pharma’s Shares Plunges Following FDA Letter"

Advertisement
Quick Search
Advertisement
Advertisement